BIOMAT Database Logo BIOMAT Database Logo

Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator. 1994

C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Service de Cardiologie et Médicine Interne, Hôpital Saint-André, Bordeaux, France.

We report the case of a woman treated with urokinase for acute pulmonary embolism with a right-sided heart thrombus. She developed life-threatening acute cor pulmonale which dramatically improved within 4 h with recombinant tissue plasminogen activator (rtPA). We emphasize the clinical interest of rtPA for the treatment of life-threatening pulmonary embolism.

UI MeSH Term Description Entries
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
In vivo right heart thrombus. Precursor of life-threatening pulmonary embolism.
December 1988, Chest,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator.
January 1997, Cardiovascular and interventional radiology,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Life threatening cavopulmonary thrombus: resolution within 24 h with tissue plasminogen activator.
April 2008, Paediatric anaesthesia,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Successful treatment of mobile right atrial thrombus and acute pulmonary embolism with intravenous tissue plasminogen activator.
July 2013, BMJ case reports,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
January 2012, The American journal of emergency medicine,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Rapid resolution of pulmonary embolism by tissue plasminogen activator.
November 1989, Clinical nuclear medicine,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism.
October 2011, The American journal of emergency medicine,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Treatment of pulmonary embolism during cesarean section with recombinant tissue plasminogen activator.
October 1998, Anesthesiology,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.
July 2014, Journal of perinatology : official journal of the California Perinatal Association,
C d'Ivernois, and P Le Metayer, and B Fischer, and M Haissaguerre, and J F Warin
[Recombinant tissue-type plasminogen activator for the emergency treatment of perioperative life-threatening pulmonary embolism (stage IV). Results in 7 patients].
June 1991, Der Anaesthesist,
Copied contents to your clipboard!